← Leaderboards
Todd K Rosengart
Evanston Northwestern Healthcare
$11,934,457
Attributed
$12,364,457
Total exposure
8
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2009–25$2M$1.5M$1M$500K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$12,364,457 · 8
By mechanism
R01$8,322,517 · 4
T32$2,583,800 · 1
U01$598,140 · 1
R61$560,000 · 1
R43$300,000 · 1
Top collaborators
- Henricus Duckers1 shared
- Tamer M A Mohamed1 shared
Others in their field
Top investigators on “Vascular Endothelial Growth Factors”
- Keri Hammel · The Emmes Company, Llc$41,089,609
- Michael Simons · Yale University$37,207,792
- Norman Wolmark · Nsabp Foundation, Inc.$27,593,122
- Shahin Rafii · Weill Medical College Of Cornell Univ$24,406,332
- Rakesh K. Jain · Massachusetts General Hospital$23,479,897
- Aleksander S. Popel · Johns Hopkins University$19,039,579
Research focus
Vascular Endothelial Growth FactorsRattusIn VitroMyocardiumFamily SuidaeGenerationsIn VivoAngiogenesisStem CellsCellsPre-ClinicalGenesGene ExpressionChronicTranscription FactorMediatingClinical ResearchCoronaryClinical TrialsFibroblastsMyocardial InfarctionPathway InteractionsCardiac MyocytesCardiac
Grant awards (30)
Triple Gene Therapy for Ischemic Heart Failure$560,000
R61 · FY2025 · HL
Research Training Program in Cardiovascular Surgery$361,398
T32 · FY2025 · HL · contact PI
Research Training Program in Cardiovascular Surgery$364,748
T32 · FY2024 · HL · contact PI
Cell Plasticity-Based Reprogramming Strategies to Enhance Human Myocardial Regeneration$635,488
R01 · FY2023 · HL · contact PI
Research Training Program in Cardiovascular Surgery$348,466
T32 · FY2023 · HL · contact PI
Combined Pro-Plasticity Reprogramming Strategies to Enhance Post-Infarction Myocardial Recovery$300,000
R43 · FY2023 · HL
Cell Plasticity-Based Reprogramming Strategies to Enhance Human Myocardial Regeneration$628,589
R01 · FY2022 · HL · contact PI
Research Training Program in Cardiovascular Surgery$303,072
T32 · FY2022 · HL · contact PI
Cell Plasticity-Based Reprogramming Strategies to Enhance Human Myocardial Regeneration$631,200
R01 · FY2021 · HL · contact PI
Research Training Program in Cardiovascular Surgery$356,425
T32 · FY2021 · HL · contact PI
Cell Plasticity-Based Reprogramming Strategies to Enhance Human Myocardial Regeneration$626,400
R01 · FY2020 · HL · contact PI
Research Training Program in Cardiovascular Surgery$351,772
T32 · FY2020 · HL · contact PI
Research Training Program in Cardiovascular Surgery$335,788
T32 · FY2019 · HL · contact PI
In Situ Cardiac Infarct Cellular Reprogramming$681,002
R01 · FY2018 · HL · contact PI
Research Training Program in Cardiovascular Surgery$162,131
T32 · FY2018 · HL · contact PI
In Situ Cardiac Infarct Cellular Reprogramming$681,002
R01 · FY2017 · HL · contact PI
In Situ Cardiac Infarct Cellular Reprogramming$681,002
R01 · FY2016 · HL · contact PI
In Situ Cardiac Infarct Cellular Reprogramming$681,002
R01 · FY2015 · HL · contact PI
EGR-1 Mediated Revascularization and Arteriogenic Bypass$318,147
R01 · FY2013 · HL · contact PI
EGR-1 Mediated Revascularization and Arteriogenic Bypass$388,575
R01 · FY2012 · HL · contact PI
EGR-1 Mediated Revascularization and Arteriogenic Bypass$392,500
R01 · FY2011 · HL · contact PI
EGR-1 Mediated Revascularization and Arteriogenic Bypass$391,250
R01 · FY2010 · HL · contact PI
EGR-1 Mediated Revascularization and Arteriogenic Bypass$386,360
R01 · FY2009 · HL · contact PI
ANGIOGENIC BYPASS &GENE THERAPY RESPONSE MECHANISMS$300,000
R01 · FY2003 · HL
ANGIOGENIC BYPASS &GENE THERAPY RESPONSE MECHANISMS$300,000
R01 · FY2002 · HL
ADENOVIRUS MEDIATED VEGF121 CDNA MYOCARDIAL ANGIONGENESI$199,380
U01 · FY2002 · HL
ANGIOGENIC BYPASS &GENE THERAPY RESPONSE MECHANISMS$300,000
R01 · FY2001 · HL
ADENOVIRUS MEDIATED VEGF121 CDNA MYOCARDIAL ANGIONGENESI$199,380
U01 · FY2001 · HL
ANGIOGENIC BYPASS &GENE THERAPY RESPONSE MECHANISMS$300,000
R01 · FY2000 · HL
ADENOVIRUS MEDIATED VEGF121 CDNA MYOCARDIAL ANGIONGENESI$199,380
U01 · FY2000 · HL